Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Neurology | Orthopedics/Orthopedic Surgery
Disease Category: Reflex Sympathetic Dystrophy Syndrome (RSDS)
Location: United States, FL
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zolendronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
This is a randomized, double-blind, placebo-controlled, 24-week study to evaluate the efficacy and safety of AXS-02 in patients with CRPS-I.
CW ID: 209807
Date Last Changed:
February 15, 2017
Key Inclusion Criteria:
Key Exclusion Criteria:
Protocol Number: AXS02-301
Brittany HarveyUniversity of South Florida- Morsani Center for Advanced Healthcare13330 USF Laurel DriveTampa, FL 33613Phone: 813-974-9413
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.